Glaucoma Clinical Trial
Official title:
A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products
Verified date | June 2024 |
Source | Johnson & Johnson Surgical Vision, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.
Status | Enrolling by invitation |
Enrollment | 3000 |
Est. completion date | May 31, 2025 |
Est. primary completion date | May 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: 1. Patients who have been implanted with and/or undergone ophthalmic surgery using targeted JJSV products 2. Status post ophthalmic surgery between 1 day and 24 months for Year 1. Subsequent years after Year 1 will be between 1 day and 18 months. Exclusion Criteria: 1. Concurrent participation (during the retrospective follow-up period) in an interventional (drug, device, biologic, etc.) clinical trial 2. Use of surgical devices not in accordance with the product labeling or indications for use 3. Degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that cause visual acuity losses to a level worse than 0.2 logMAR (0.63 decimal, 6/9.5 or 20/32 Snellen) during the retrospective data collection period 4. Use of systemic or ocular medications that may affect vision during the retrospective data collection period 5. Known ocular disease or pathology that, in the opinion of the investigator may confound study findings during the retrospective data collection period 6. Pregnancy, lactating, or other condition associated with hormonal fluctuation that could lead to refractive changes during the retrospective data collection period. |
Country | Name | City | State |
---|---|---|---|
Germany | Augenaerzte Gerl & Kollegen MVZ Ahaus GmbH | Ahaus | Nordrhein-Westfalen |
Germany | Augentagesklinik Spreebogen Berlin GbR | Berlin | |
Germany | Augenzentrum Erzgebirge | Zschopau | SN |
Spain | Clinica Vistahermosa | Alicante | Alacant |
Spain | Hosp. De La Santa Creu I Sant Pau | Barcelona | CT |
Spain | Hospital La Arruzafa | Cordoba | Andalusia |
Spain | Clinica Oftalvist | Madrid | |
Spain | Hospital Clinico San Carlos | Madrid | MD |
Spain | Instituto Universitario de Oftalmobiologia Aplicada | Valladolid | CL |
United States | Empire Eye and Laser Center | Bakersfield | California |
United States | Chu Vision Institute | Bloomington | Minnesota |
United States | Trinity Research Group, LLC | Dothan | Alabama |
United States | Valley Retina Institute | McAllen | Texas |
Lead Sponsor | Collaborator |
---|---|
Johnson & Johnson Surgical Vision, Inc. |
United States, Germany, Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of Adverse Events | incidence of adverse events that are specified in the ISO 11979-7 Safety and Performance Endpoints. | up to 12 months post-operation | |
Primary | BCDVA | The proportion of eyes achieving 20/40 or better BCDVA. | up to 12 months post-operation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A |